{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:05:12Z","timestamp":1767211512101,"version":"3.37.3"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008893","name":"The University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"The University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtm.2024.101243","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:44:18Z","timestamp":1711421058000},"page":"101243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of adenoviral vectors that transduce Purkinje cells and other cerebellar cell-types in the cerebellum of a humanized mouse model"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-4057","authenticated-orcid":false,"given":"Emre","family":"Kul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-7828","authenticated-orcid":false,"given":"Uchechi","family":"Okoroafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Palkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Vali\u00f1o-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Aberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-7612","authenticated-orcid":false,"suffix":"Jr.","given":"Samuel M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101243_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101243_bib3","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: The Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2024.101243_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/v13081526","article-title":"Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2024.101243_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2024.101243_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: prospects and challenges for therapy development","volume":"14","author":"Ashizawa","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2024.101243_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn.2183","article-title":"miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis","volume":"11","author":"Lee","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2024.101243_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2024.101243_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jgm.1052","article-title":"Optimized production and concentration of lentiviral vectors containing large inserts","volume":"9","author":"al Yacoub","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101243_bib11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/104303401753153947","article-title":"Systematic determination of the packaging limit of lentiviral vectors","volume":"12","author":"Kumar","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","article-title":"Viral vectors for gene delivery to the central nervous system","volume":"48","author":"Lentz","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2024.101243_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v13122502","article-title":"Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy","volume":"13","author":"Watanabe","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2024.101243_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s11262-017-1471-x","article-title":"Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models","volume":"53","author":"Brunetti-Pierri","year":"2017","journal-title":"Virus Gene."},{"key":"10.1016\/j.omtm.2024.101243_bib15","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101243_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/gim.2013.28","article-title":"Hereditary ataxias: overview","volume":"15","author":"Jayadev","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2024.101243_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0034-1386766","article-title":"Genetic cerebellar ataxias","volume":"34","author":"Storey","year":"2014","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.omtm.2024.101243_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnsyn.2018.00006","article-title":"Purkinje Cell Signaling Deficits in Animal Models of Ataxia","volume":"10","author":"Hoxha","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.omtm.2024.101243_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101243_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","article-title":"An anatomically comprehensive atlas of the adult human brain transcriptome","volume":"489","author":"Hawrylycz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101243_bib21","first-page":"185","article-title":"A human protein atlas based on antibody proteomics","volume":"8","author":"Persson","year":"2006","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.omtm.2024.101243_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004290050105","article-title":"Retrograde and anterograde labeling of cerebellar afferent projection by the injection of recombinant adenoviral vectors into the mouse cerebellar cortex","volume":"196","author":"Terashima","year":"1997","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.omtm.2024.101243_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/hum.1996.7.2-149","article-title":"A neural cell-type-specific expression system using recombinant adenovirus vectors","volume":"7","author":"Hashimoto","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneumeth.2004.02.014","article-title":"Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum","volume":"137","author":"Sato","year":"2004","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.omtm.2024.101243_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1098-1136(200008)31:2<144::AID-GLIA60>3.0.CO;2-6","article-title":"Restriction of high CD15 expression to a subset of rat cerebellar astroglial cells can be overcome by transduction with adenoviral vectors expressing the rat alpha 1,3-fucosyltransferase IV gene","volume":"31","author":"Baboval","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.omtm.2024.101243_bib26","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/JVI.76.9.4612-4620.2002","article-title":"Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease","volume":"76","author":"Havenga","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101243_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-398342-8.00002-1","article-title":"Chapter two--Adenovirus strategies for tissue-specific targeting","volume":"115","author":"Beatty","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.omtm.2024.101243_bib28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101243_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1357-2725(99)00092-8","article-title":"Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions","volume":"31","author":"Seya","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2024.101243_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0161-5890(93)90038-D","article-title":"Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing","volume":"30","author":"Johnstone","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2024.101243_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80050-1","article-title":"Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease","volume":"98","author":"Oldstone","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101243_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.omtm.2017.07.006","article-title":"Minimal Purkinje Cell-Specific PCP2\/L7 Promoter Virally Available for Rodents and Non-human Primates","volume":"6","author":"Nitta","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101243_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","article-title":"In\u00a0vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2024.101243_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139538","article-title":"Curative in\u00a0vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2024.101243_bib35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In\u00a0vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101243_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat7615","article-title":"Integrative functional genomic analysis of human brain development and neuropsychiatric risks","volume":"362","author":"Li","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101243_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8077","article-title":"Spatiotemporal transcriptomic divergence across human and macaque brain development","volume":"362","author":"Zhu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101243_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cas.13228","article-title":"Recent advances in genetic modification of adenovirus vectors for cancer treatment","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omtm.2024.101243_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(94)91919-4","article-title":"Adenoviral vectors as functional retrograde neuronal tracers","volume":"648","author":"Ridoux","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2024.101243_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng0393-224","article-title":"Transfer of a foreign gene into the brain using adenovirus vectors","volume":"3","author":"Akli","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2024.101243_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng0393-229","article-title":"Direct in\u00a0vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors","volume":"3","author":"Bajocchi","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2024.101243_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101585","article-title":"The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal","volume":"13","author":"Nesti\u0107","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2024.101243_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/mcne.2000.0929","article-title":"Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors","volume":"17","author":"K\u00fcgler","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2024.101243_bib44","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1093\/hmg\/ddz148","article-title":"Next-generation AAV vectors-do not judge a virus (only) by its cover","volume":"28","author":"Domenger","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101243_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtm.2024.101243_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O","article-title":"Projection patterns of single mossy fibers originating from the lateral reticular nucleus in the rat cerebellar cortex and nuclei","volume":"411","author":"Wu","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2024.101243_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858410380251","article-title":"Topsy turvy: functions of climbing and mossy fibers in the vestibulo-cerebellum","volume":"17","author":"Barmack","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.omtm.2024.101243_bib48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jgm.543","article-title":"Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells","volume":"6","author":"Nilsson","year":"2004","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101243_bib49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/hum.2005.16.664","article-title":"Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons","volume":"16","author":"Ni","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib50","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1128\/JVI.01964-09","article-title":"Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses","volume":"84","author":"Cupelli","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101243_bib51","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"In\u00a0vitro and in\u00a0vivo properties of adenovirus vectors with increased affinity to CD46","volume":"82","author":"Wang","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101243_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnmol.2020.00009","article-title":"Canine Adenovirus 2: A Natural Choice for Brain Circuit Dissection","volume":"13","author":"Lavoie","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2024.101243_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018205","article-title":"Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction","volume":"6","author":"Corjon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101243_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/mt.2008.19","article-title":"Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman Primates","volume":"16","author":"Sakurai","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib55","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/WNL.0000000000012952","article-title":"Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial","volume":"98","author":"Christine","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2024.101243_bib56","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp-2020-322904","article-title":"Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease","volume":"91","author":"Richardson","year":"2020","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.omtm.2024.101243_bib57","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ymthe.2023.04.009","article-title":"Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease","volume":"31","author":"Rocco","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101243_bib58","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.3233\/JPD-212724","article-title":"An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function","volume":"11","author":"Van Laar","year":"2021","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.omtm.2024.101243_bib59","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3171\/2020.4.JNS20701","article-title":"Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders","volume":"134","author":"Lonser","year":"2020","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.omtm.2024.101243_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12311-010-0161-1","article-title":"High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in\u00a0vivo","volume":"9","author":"Sawada","year":"2010","journal-title":"Cerebellum"},{"key":"10.1016\/j.omtm.2024.101243_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.05.015","article-title":"Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters","volume":"1620","author":"Kim","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2024.101243_bib62","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101243_bib63","first-page":"389","article-title":"Construction of first-generation adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.omtm.2024.101243_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.gt.3301197","article-title":"A simple method for the rapid generation of recombinant adenovirus vectors","volume":"7","author":"Anderson","year":"2000","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T11:04:40Z","timestamp":1726398280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2329050124000597"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101243","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of adenoviral vectors that transduce Purkinje cells and other cerebellar cell-types in the cerebellum of a humanized mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101243"}}